Background This study aimed to gather insights in physicians' considerations for decisions to either refer for- or to withhold additional diagnostic investigations in nursing home patients with a suspicion of venous thromboembolism. Methods Our study was nested in an observational study on diagnostic strategies for suspected venous thromboembolism in nursing home patients. Patient characteristics, bleeding-complications and mortality were related to the decision to withhold investigations. For a better understanding of the physicians' decisions, 21 individual face-to-face in-depth interviews were performed and analysed using the grounded theory approach. Results Referal for additional diagnostic investigations was forgone in 126/322 (39.1%) patients with an indication for diagnostic work-up. ‘Blind’ anticoagulant treatment was initiated in 95 (75.4%) of these patients. The 3month mortality rates were higher for patients in whom investigations were withheld than in the referred patients, irrespective of anticoagulant treatment (odds ratio 2.45; 95% confidence interval 1.40 to 4.29) but when adjusted for the probability of being referred (i.e. the propensity score), there was no relation of non-diagnosis decisions to mortality (odds ratio 1.75; 0.98 to 3.11). In their decisions to forgo diagnostic investigations, physicians incorporated the estimated relative impact of the potential disease; the potential net-benefits of diagnostic investigations and whether performing investigations agreed with established management goals in advance care planning. Conclusion Referral for additional diagnostic investigations is withheld in almost 40% of Dutch nursing home patients with suspected venous thromboembolism and an indication for diagnostic work-up. We propose that, given the complexity of these decisions and the uncertainty regarding their indirect effects on patient outcome, more attention should be focused on the decision to either use or withhold additional diagnostic tests.
References
[1]
White RH (2003) The epidemiology of venous thromboembolism. Circulation 107: I4–I8. doi: 10.1161/01.cir.0000078468.11849.66
[2]
Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, et al. (1998) Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 158: 585–593. doi: 10.1001/archinte.158.6.585
[3]
Masotti L, Ray P, Righini M, Le Gal G, Antonelli F, et al. (2008) Pulmonary embolism in the elderly: a review on clinical, instrumental and laboratory presentation. Vasc Health Risk Manag 4: 629–636.
[4]
Goodacre S, Sutton AJ, Sampson FC (2005) Meta-analysis: The value of clinical assessment in the diagnosis of deep venous thrombosis. Ann Intern Med 143: 129–139. doi: 10.7326/0003-4819-143-2-200507190-00012
[5]
Oudega R, Moons KG, Hoes AW (2005) Limited value of patient history and physical examination in diagnosing deep vein thrombosis in primary care. Fam Pract 22: 86–91. doi: 10.1093/fampra/cmh718
[6]
Righini M, Le Gal G, Perrier A, Bounameaux H (2005) The challenge of diagnosing pulmonary embolism in elderly patients: influence of age on commonly used diagnostic tests and strategies. J Am Geriatr Soc 53: 1039–1045. doi: 10.1111/j.1532-5415.2005.53309.x
[7]
Schouten HJ, Geersing GJ, Koek HL, Zuithoff NP, Janssen KJ, et al. (2013) Diagnostic accuracy of conventional or age adjusted D-dimer cut-off values in older patients with suspected venous thromboembolism: systematic review and meta-analysis. BMJ 346: f2492. doi: 10.1136/bmj.f2492
[8]
Di Nisio M, Squizzato A, Rutjes AW, Buller HR, Zwinderman AH, et al. (2007) Diagnostic accuracy of D-dimer test for exclusion of venous thromboembolism: a systematic review. J Thromb Haemost 5: 296–304. doi: 10.1111/j.1538-7836.2007.02328.x
[9]
Wells PS (2007) Integrated strategies for the diagnosis of venous thromboembolism. J Thromb Haemost 5 Suppl 1: 41–50. doi: 10.1111/j.1538-7836.2007.02493.x
[10]
Gozalo P, Teno JM, Mitchell SL, Skinner J, Bynum J, et al. (2011) End-of-life transitions among nursing home residents with cognitive issues. N Engl J Med 365: 1212–1221. doi: 10.1056/nejmsa1100347
[11]
Gill TM, Gahbauer EA, Han L, Allore HG (2011) The relationship between intervening hospitalizations and transitions between frailty states. J Gerontol A Biol Sci Med Sci 66: 1238–1243. doi: 10.1093/gerona/glr142
[12]
Goldfeld KS, Hamel MB, Mitchell SL (2013) The Cost-Effectiveness of the Decision to Hospitalize Nursing Home Residents With Advanced Dementia. J Pain Symptom Manage 10. doi: 10.1016/j.jpainsymman.2012.11.007
[13]
Gillick MR, Serrell NA, Gillick LS (1982) Adverse consequences of hospitalization in the elderly. Soc Sci Med 16: 1033–1038. doi: 10.1016/0277-9536(82)90175-7
[14]
Mitchell AM, Jones AE, Tumlin JA, Kline JA (2012) Prospective study of the incidence of contrast-induced nephropathy among patients evaluated for pulmonary embolism by contrast-enhanced computed tomography. Acad Emerg Med 19: 618–625. doi: 10.1111/j.1553-2712.2012.01374.x
[15]
Wiener RS, Schwartz LM, Woloshin S (2013) When a test is too good: how CT pulmonary angiograms find pulmonary emboli that do not need to be found. BMJ 347: f3368. doi: 10.1136/bmj.f3368
[16]
Prasad V, Rho J, Cifu A (2012) The diagnosis and treatment of pulmonary embolism: a metaphor for medicine in the evidence-based medicine era. Arch Intern Med 172: 955–958. doi: 10.1001/archinternmed.2012.195
[17]
Schouten HJ, van Ginkel S, Koek HL, Geersing GJ, Oudega R, et al. (2012) Non-diagnosis decisions and non-treatment decisions in elderly patients with cardiovascular diseases, do they differ?–A systematic review. J Am Med Dir Assoc 13: 682–687. doi: 10.1016/j.jamda.2012.05.010
[18]
Hamaker ME, Hamelinck VC, van Munster BC, Bastiaannet E, Smorenburg CH, et al. (2012) Nonreferral of nursing home patients with suspected breast cancer. J Am Med Dir Assoc 13: 464–469. doi: 10.1016/j.jamda.2012.01.002
[19]
Glaser BG, Strauss AL (1967) The discovery of grounded theory. Strategies for Qualitative Research. Chicago: Aldine Publishing Company.
[20]
Boeije H (2010) Analysis in qualitative research. SAGE Publications doi: 10.5785/26-2-24
[21]
Koopmans RT, Lavrijsen JC, Hoek JF, Went PB, Schols JM (2010) Dutch elderly care physician: a new generation of nursing home physician specialists. J Am Geriatr Soc 58: 1807–1809. doi: 10.1111/j.1532-5415.2010.03043.x
[22]
Oudega R, Moons KG, Hoes AW (2005) Ruling out deep venous thrombosis in primary care. A simple diagnostic algorithm including D-dimer testing. Thromb Haemost 94: 200–205. doi: 10.1160/th04-12-0829
[23]
Wells PS, Anderson DR, Rodger M, Ginsberg JS, Kearon C, et al. (2000) Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost 83: 416–420.
[24]
(2002) Code of Conduct for Medical Research. Available: www.federa.org
[25]
Lingard L, Albert M, Levinson W (2008) Grounded theory, mixed methods, and action research. BMJ 337: a567. doi: 10.1136/bmj.39602.690162.47
[26]
Dierckx de CB, Gastmans C, Bryon E, Denier Y (2012) QUAGOL: a guide for qualitative data analysis. Int J Nurs Stud 49: 360–371. doi: 10.1016/j.ijnurstu.2011.09.012
[27]
Pope C, Ziebland S, Mays N (2000) Qualitative research in health care. Analysing qualitative data. BMJ 320: 114–116. doi: 10.1136/bmj.320.7227.114
[28]
AVVV, NVVA, Sting (2006) Begrippen en Zorgvuldigheidseisen met betrekking tot de besluitvorming rond het levenseinde in de verpleeghuiszorg.
[29]
Givens JL, Selby K, Goldfeld KS, Mitchell SL (2012) Hospital transfers of nursing home residents with advanced dementia. J Am Geriatr Soc 60: 905–909. doi: 10.1111/j.1532-5415.2012.03919.x
[30]
Fried TR, Mor V (1997) Frailty and hospitalization of long-term stay nursing home residents. J Am Geriatr Soc 45: 265–269.
[31]
Boockvar K, Fishman E, Kyriacou CK, Monias A, Gavi S, et al. (2004) Adverse events due to discontinuations in drug use and dose changes in patients transferred between acute and long-term care facilities. Arch Intern Med 164: 545–550. doi: 10.1001/archinte.164.5.545
[32]
Ferrante di RL, Hyde CJ, McCaffery KJ, Bossuyt PM, Deeks JJ (2012) Assessing the value of diagnostic tests: a framework for designing and evaluating trials. BMJ 344: e686. doi: 10.1136/bmj.e686
[33]
Schulman S, Beyth RJ, Kearon C, Levine MN (2008) Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133: 257S–298S. doi: 10.1378/chest.08-0674
[34]
Budnitz DS, Lovegrove MC, Shehab N, Richards CL (2011) Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 365: 2002–2012. doi: 10.1056/nejmsa1103053
[35]
Hylek EM, Evans-Molina C, Shea C, Henault LE, Regan S (2007) Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation 115: 2689–2696. doi: 10.1161/circulationaha.106.653048
[36]
Barrit DW, Jordan SC (1960) Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet 1: 1309–1312. doi: 10.1016/s0140-6736(60)92299-6
[37]
Khreizat HS, Whittaker P, Curtis KD, Turlo G, Garwood CL (2012) The effect of cognitive impairment in the elderly on the initial and long-term stability of warfarin therapy. Drugs Aging 29: 307–317. doi: 10.2165/11599060-000000000-00000
[38]
Helton MR, van der Steen JT, Daaleman TP, Gamble GR, Ribbe MW (2006) A cross-cultural study of physician treatment decisions for demented nursing home patients who develop pneumonia. Ann Fam Med 4: 221–227. doi: 10.1370/afm.536
[39]
Ling J, Rees E, Hardy J (2000) What influences participation in clinical trials in palliative care in a cancer centre? Eur J Cancer 36: 621–626. doi: 10.1016/s0959-8049(99)00330-5
